Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
HPK vs VET: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HPK Captures Overall Composite Edge (72.5 BUY vs 71.1 BUY), While VET Leads 5–1 on Growth & Valuation Pillars
HPK Overall Winner
6-Pillar Tally: HPK 1 – 5 VET
Matrix Metrics: HPK 5 – 5 VET
As of Nov 20, 2026, HighPeak Energy, Inc. (HPK) captures the overall head-to-head institutional edge over Vermilion Energy Inc. (VET) on higher Unified Composite conviction (72.5/100 BUY vs. 71.1/100 BUY) after splitting the core matrix 5–5 (led by Profitability & Quality), while VET wins 5–1 across the 6-pillar growth and valuation breakdown. HPK trades at $7.07 (24.4x Forward P/E, 18.8% operating margin) versus VET at $10.25 (17.4x Forward P/E, -0.7% operating margin).
- Growth vs. Quality Trade-Off: HPK earns the overall head-to-head edge with a stronger Unified Composite Score (72.5/100 BUY vs. VET 71.1/100 BUY) and -0.85β · 94% Vol risk profile, whereas VET leads top-line expansion (+30.4% YoY revenue growth, 3.58x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: HPK is currently in a Breakdown options structure phase (RSI 36.5); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HPK vs VET
HPK
Head-to-Head Winner
HighPeak Energy, Inc. Common Stock
$7.07
-0.42% 1D
Market Cap
$898.4M
TTM Revenue
$911M
Forward P/E
24.4x
Beta / 30D Vol
-0.85β · 94% Vol
Unified Composite Score
72.5
BUY
Tech 91.0
Fund 73.0
Flow 54.0
Mom 70.0
Weinstein Technical Phase
Neutral · Hold
VET
Vermilion Energy Inc.
$10.25
-1.06% 1D
Market Cap
$1.6B
TTM Revenue
$1.97B
Forward P/E
17.4x
Beta / 30D Vol
-0.77β · 61% Vol
Unified Composite Score
71.1
BUY
Tech 84.0
Fund 71.0
Flow 56.0
Mom 70.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (HPK 1 – 5 VET)
1. Valuation Multiples
VET
Forward P/E
24.4x
17.4x
Trailing P/E
32.7x
17.4x
PEG Ratio
N/M
3.58x
EV / Revenue
2.1x
1.4x
2. Growth & Scale
VET
Revenue Growth (YoY)
+23.0%
+30.4%
Earnings Growth (YoY)
+215.2%
-94.9%
TTM Revenue (USD)
$911M
$1.97B
Market Cap
$898.4M
$1.6B
3. Profitability & Quality
HPK
Gross Margin
73.4%
64.0%
Operating Margin
18.8%
-0.7%
Net Profit Margin
-13.8%
-24.6%
Return on Equity (ROE)
-8.1%
-20.1%
4. Balance Sheet & Cash Flow
VET
Cash Generation (TTM)
-$10M
$1.31B
Cash Flow Margin
-1.1%
66.5%
Net Cash / Leverage
$1.04B Net Debt (0.78x D/E)
$1.18B Net Debt (0.59x D/E)
Dividend Yield
0.56%
5.20%
5. Options & Positioning
VET
Options Structure Phase
BREAKDOWN
CONSOLIDATION
Current IV / %ile
109.3% (82nd %ile)
46.5% (23rd %ile)
Put/Call OI Skew
0.57x (Call-Skewed)
0.30x (Call-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
VET
OpEx & R&D Intensity
54.6% of Rev ($497M)
64.7% of Rev ($1.27B)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Oil & Gas E&P Operator
Oil & Gas E&P Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HPK (5) vs VET (5)| Institutional Metric | HPK | VET | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $898.4M | $1.6B | VET | |
| Trailing P/E Ratio | 32.7x | 17.4x | VET | |
| Forward P/E Ratio | 24.4x | 17.4x | VET | |
| Revenue Growth (YoY) | +23.0% | +30.4% | VET | |
| Operating Margin (TTM) | 18.8% | -0.7% | HPK | |
| Net Profit Margin | -13.8% | -24.6% | HPK | |
| Return on Equity (ROE) | -8.1% | -20.1% | HPK | |
| 52-Week Range Position | 39% ($4–$12) | 35% ($8–$15) | HPK | |
| Beta / 30D Volatility | -0.85β · 94% Vol | -0.77β · 61% Vol | VET | |
| Unified Institutional Score | 72.5 / 100 (BUY) | 71.1 / 100 (BUY) | HPK | |
| Trailing 12M Revenue (USD) | $911M | $1.97B | Scale | |
| Gross Profit Margin (TTM) | 73.4% | 64.0% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 2.1x EV/Rev | 3.58x PEG · 1.4x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$10M ($1.04B Net Debt (0.78x D/E)) | $1.31B ($1.18B Net Debt (0.59x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
VET +13.14 pp
3M Horizon
HPK +5.22 pp
6M Horizon
HPK +6.73 pp
1Y Horizon
HPK +12.75 pp
Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | HPK Revenue | VET Revenue | HPK Op. Margin | VET Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| Q3 '25 | $830M | $1.86B | 15.7% | 6.7% | HPK |
| Q4 '25 | $870M | $1.85B | -7.5% | -0.8% | VET |
| Q1 '26 | $860M | $2.08B | 16.7% | 19.6% | VET |
| Q2 '26 | $1.09B | $2.25B | 30.6% | 23.9% | HPK |
| Q3 '26 | $1.03B | $2.44B | 27.9% | 25.8% | HPK |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HPK
BREAKDOWN
Current IV
109.3%
IV Percentile
82nd %ile
Put/Call OI Skew
0.57x (Call-Skewed)
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
NEUTRAL
Exact HPK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
VET
CONSOLIDATION
Current IV
46.5%
IV Percentile
23rd %ile
Put/Call OI Skew
0.30x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact VET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HPK Moat Profile
Scale & Operating Efficiency Moat
Oil & Gas E&P Operator
OpEx & R&D Reinvestment
54.6% of Rev ($497M)
90D Engineering Disclosures
0 Published
VET Moat Profile
Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
OpEx & R&D Reinvestment
64.7% of Rev ($1.27B)
90D Engineering Disclosures
0 Published
Investor FAQ HPK vs VET Key Questions & Quantitative Answers
As of Nov 20, 2026, HighPeak Energy, Inc. (HPK) captures the overall head-to-head institutional edge over Vermilion Energy Inc. (VET) on higher Unified Composite conviction (72.5/100 BUY vs. 71.1/100 BUY) after splitting the core matrix 5–5 (led by Profitability & Quality), while VET wins 5–1 across the 6-pillar growth and valuation breakdown. HPK trades at $7.07 (24.4x Forward P/E, 18.8% operating margin) versus VET at $10.25 (17.4x Forward P/E, -0.7% operating margin). Growth vs. Quality Trade-Off: HPK earns the overall head-to-head edge with a stronger Unified Composite Score (72.5/100 BUY vs. VET 71.1/100 BUY) and -0.85β · 94% Vol risk profile, whereas VET leads top-line expansion (+30.4% YoY revenue growth, 3.58x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HPK is currently in a Breakdown options structure phase (RSI 36.5); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VET leads the Growth & Scale pillar: HPK posts +23.0% YoY revenue growth and +215.2% YoY earnings growth on $911M TTM revenue (73.4% gross margin, 18.8% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), HPK cumulative revenue shifted +24.1% while VET shifted +31.2%. In operating R&D and SG&A reinvestment, HPK deploys 54.6% of Rev ($497M) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.
VET screens cheaper on headline valuation multiples. HPK trades at 24.4x Forward P/E, 32.7x Trailing P/E, N/M PEG, and 2.1x EV/Revenue (-1.1% FCF margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HPK (-8.1% ROE) versus VET (-20.1% ROE) capital efficiency.
In options market volatility and institutional positioning, HPK carries 109.3% implied volatility (82nd %ile, Extreme (>80th %ile)), a 0.57x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-0.85β · 94% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
VET vs HPK · Reverse Pair
HPK vs MGY
· Sector Peer
HPK vs EE
· Sector Peer
HPK vs TALO
· Sector Peer
VET vs OVV
· Sector Peer
VET vs CVE
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem